Showing results (81-90 of 1,860) with videos related to
Sort By:
Pageof 186
Biochemistry|September 20, 1994
Solution structure of a low molecular weight protein tyrosine phosphataseT M Logan, M M Zhou, D G Nettesheim, et al.Journal of Medicinal Chemistry|October 29, 2000
Identification of novel inhibitors of urokinase via NMR-based screeningP J Hajduk, S Boyd, D Nettesheim, et al.Cell|March 21, 2001
Structural basis for the inhibition of caspase-3 by XIAPS J Riedl, M Renatus, R Schwarzenbacher, et al.Gene Therapy|September 30, 2011
Tumor vasculature is a key determinant for the efficiency of nanoparticle-mediated siRNA deliveryL Li, R Wang, D Wilcox, et al.The Journal of Biological Chemistry|August 10, 2000
NMR structure and mutagenesis of the third Bir domain of the inhibitor of apoptosis protein XIAPC Sun, M Cai, R P Meadows, et al.The Journal of Biological Chemistry|December 29, 1995
Binding affinities of tyrosine-phosphorylated peptides to the COOH-terminal SH2 and NH2-terminal phosphotyrosine binding domains of ShcM M Zhou, J E Harlan, W S Wade, et al.Nature|May 15, 1998
NMR structure and mutagenesis of the FADD (Mort1) death-effector domainM Eberstadt, B Huang, Z Chen, et al.Nature Structural Biology|June 1, 1997
Solution structure of an rRNA methyltransferase (ErmAM) that confers macrolide-lincosamide-streptogramin antibiotic resistanceL Yu, A M Petros, A Schnuchel, et al.Oncogene|December 19, 2006
'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737X Lin, S Morgan-Lappe, X Huang, et al.Molecular and Cellular Biology|September 1, 1997
Evidence for a requirement for both phospholipid and phosphotyrosine binding via the Shc phosphotyrosine-binding domain in vivoK S Ravichandran, M M Zhou, J C Pratt, et al.Pageof 186